Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INTRINSIC EFFICACY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 51 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Menziani, MC; De Rienzo, F; Cappelli, A; Anzini, M; De Benedetti, PG
      A computational model of the 5-HT3 receptor extracellular domain: search for ligand binding sites

      THEORETICAL CHEMISTRY ACCOUNTS
    2. Baglin, I; Daveu, C; Lancelot, JC; Bureau, R; Dauphin, F; Pfeiffer, B; Renard, P; Delagrange, P; Rault, S
      First tricyclic oximino derivatives as 5-HT3 ligands

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Parihar, HS; Suryanarayanan, A; Ma, C; Joshi, P; Venkataraman, P; Schulte, MK; Kirschbaum, KS
      5-HT3R binding of lerisetron: An interdisciplinary approach to drug-receptor interactions

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Barrett, AC; Morgan, D; Izenwasser, S; Picker, MJ
      Cocaine-like discriminative stimulus effects and [H-3]dopamine uptake inhibition produced by selected partial opioid agonists

      BEHAVIOURAL PHARMACOLOGY
    5. Oh, SJ; Ha, HJ; Chi, DY; Lee, HK
      Serotonin receptor and transporter ligands - Current status

      CURRENT MEDICINAL CHEMISTRY
    6. Xu, H; Lu, YF; Thomas, JB; Carroll, FI; Rice, KC; Rothman, RB
      Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4 piperidinyl) phenylamino]-N,N-diethylbenzamide and related compoundsat the cloned human delta-opioid receptor

      SYNAPSE
    7. Xu, H; Hashimoto, A; Rice, KC; Jacobson, AE; Thomas, JB; Carroll, FI; Lai, J; Rothman, RB
      Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [S-35]GTP-gamma-S functional binding assay

      SYNAPSE
    8. Compton, P; Charuvastra, VC; Ling, W
      Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent

      DRUG AND ALCOHOL DEPENDENCE
    9. Angeles, DM; Williams, J; Purdy, RE; Zhang, LB; Pearce, WJ
      Effects of maturation and acute hypoxia on receptor-IP3 coupling in ovine common carotid arteries

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    10. Bureau, R; Daveu, C; Baglin, I; Santos, JSD; Lancelot, JC; Rault, S
      Association of two 3D QSAR analyses. Application to the study of partial agonist serotonin-3 ligands

      JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES
    11. Zefirova, ON; Zefirov, NS
      Physiologically active compounds interacting with serotonin (5-hydroxytryptamine) receptors

      USPEKHI KHIMII
    12. Carey, GJ; Bergman, J
      Enadoline discrimination in squirrel monkeys: Effects of opioid agonists and antagonists

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Inoue, A; Nakata, Y
      Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy

      JAPANESE JOURNAL OF PHARMACOLOGY
    14. Adam, F; Le Bars, D; Chauvin, M; Guirimand, F
      Effects of intravenous and intrathecal sufentanil on a C-fibre reflex elicited by a wide range of stimulus intensities in the rat

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Smith, MA; Gray, JD
      Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats - Influence of nociceptive intensity and intrinsic efficacy at the mu receptor

      PSYCHOPHARMACOLOGY
    16. Walker, EA; Picker, MJ; Dykstra, LA
      Three-choice discrimination in pigeons is based on relative efficacy differences among opioids

      PSYCHOPHARMACOLOGY
    17. Lee, BS; Chu, S; Lee, BC; Chi, DY; Choe, YS; Jeong, KJ; Jin, C
      Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 1

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    18. Robichaud, AJ; Largent, BL
      Recent advances in selective serotonin receptor modulation

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    19. Allen, RM; Dykstra, LA
      Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    20. Alberts, GL; Pregenzer, JF; Im, WB
      Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells

      BRITISH JOURNAL OF PHARMACOLOGY
    21. Cook, CD; Barrett, AC; Roach, EL; Bowman, JR; Picker, MJ
      Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the muopioid receptor

      PSYCHOPHARMACOLOGY
    22. Griebel, G; Perrault, G; Sanger, DJ
      Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: Evaluation of the importance of intrinsic efficacy and receptor subtype selectivity

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    23. Wala, EP; Sloan, JW; Jing, X
      Substantia nigra: The involvement of central and peripheral benzodiazepinereceptors in physical dependence on diazepam as evidenced by behavioral and EEG effects

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    24. Grabus, SD; Smurthwaite, ST; Riley, AL
      Nalorphine's ability to substitute for morphine in a drug discrimination procedure is a function of training dose

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    25. Jones, HE; Bigelow, GE; Preston, KL
      Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    26. Tuk, B; Van Oostenbruggen, MF; Herben, VMM; Mandema, JW; Danhof, M
      Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: Midazolam and alpha-OH-midazolam

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    27. Alberts, GL; Pregenzer, JF; Im, WB; Zaworski, PG; Gill, GS
      Agonist-induced GTP gamma S-35 binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Gupta, P; Scatchard, J; Napier, C; McHarg, A; Wallis, R
      Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor

      EUROPEAN JOURNAL OF PHARMACOLOGY
    29. Cleton, A; Mazee, D; Voskuyl, RA; Danhof, M
      Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats

      BRITISH JOURNAL OF PHARMACOLOGY
    30. Christopoulos, A; El-Fakahany, EE
      Qualitative and quantitative assessment of relative agonist efficacy

      BIOCHEMICAL PHARMACOLOGY
    31. ROWLETT JK; WOOLVERTON WL
      DISCRIMINATIVE STIMULUS EFFECTS OF BENZODIAZEPINE AGONISTS AND PARTIAL AGONISTS IN PENTOBARBITAL-TRAINED RHESUS-MONKEYS

      Behavioural pharmacology
    32. MORGAN D; PICKER MJ
      THE MU-OPIOID IRREVERSIBLE ANTAGONIST BETA-FUNALTREXAMINE DIFFERENTIATES THE DISCRIMINATIVE STIMULUS EFFECTS OF OPIOIDS WITH HIGH AND LOW EFFICACY AT THE MU-OPIOID RECEPTOR

      Psychopharmacology
    33. PICKER MJ; COOK CD
      DISCRIMINATIVE STIMULUS EFFECTS OF OPIOIDS IN PIGEONS TRAINED TO DISCRIMINATE FENTANYL, BREMAZOCINE AND WATER - EVIDENCE OF PHARMACOLOGICALSELECTIVITY

      Behavioural pharmacology
    34. SMITH MA; PITTS RC; PICKER MJ
      TOLERANCE AND CROSS-TOLERANCE TO THE ACCURACY-DECREASING AND RATE-DECREASING EFFECTS OF MU-OPIOIDS IN RATS RESPONDING UNDER A FIXED-CONSECUTIVE-NUMBER SCHEDULE

      Drug and alcohol dependence
    35. GARNER HR; BURKE TF; LAWHORN CD; STONER JM; WESSINGER WD
      BUTORPHANOL-MEDIATED ANTINOCICEPTION IN MICE - PARTIAL AGONIST EFFECTS AND MU-RECEPTOR INVOLVEMENT

      The Journal of pharmacology and experimental therapeutics
    36. TROCONIZ IF; GARRIDO MJ; GARCIA E; SUAREZ E; CALVO R
      PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF MIVACURIUM IN RATS

      Journal of pharmaceutical sciences
    37. BOTTLAENDER M; SCHMID L; FUSEAU C; FOURNIER D; BROUILLET E; MAZIERE M
      IN-VIVO MODULATION OF BENZODIAZEPINE RECEPTOR FUNCTION AFTER INHIBITION OF ENDOGENOUS GAMMA-AMINOBUTYRIC-ACID SYNTHESIS

      European journal of pharmacology
    38. DYKSTRA LA; PRESTON KL; BIGELOW GE
      DISCRIMINATIVE STIMULUS AND SUBJECTIVE EFFECTS OF OPIOIDS WITH MU-ACTIVITY AND KAPPA-ACTIVITY - DATA FROM LABORATORY-ANIMALS AND HUMAN-SUBJECTS

      Psychopharmacology
    39. PICKER MJ; MATHEWSON C; ALLEN RM
      OPIOIDS AND RATE OF POSITIVELY REINFORCED BEHAVIOR .3. ANTAGONISM BY THE LONG-LASTING KAPPA-ANTAGONIST NORBINALTORPHIMINE

      Behavioural pharmacology
    40. HUGHES CE; DYKSTRA LA; PICKER MJ
      BEHAVIORAL TOLERANCE AND CROSS-TOLERANCE TO THE RESPONSE RATE-DECREASING EFFECTS OF MU-OPIOID IN RATS

      Behavioural pharmacology
    41. ZGOMBICK JM; SCHECHTER LE; ADHAM N; KUCHAREWICZ SA; WEINSHANK RL; BRANCHEK TA
      PHARMACOLOGICAL CHARACTERIZATIONS OF RECOMBINANT HUMAN 5-HT1D-ALPHA AND 5-HT1D-BETA RECEPTOR SUBTYPES COUPLED TO ADENYLATE-CYCLASE INHIBITION IN CLONAL CELL-LINES - APPARENT DIFFERENCES IN DRUG INTRINSIC EFFICACIES BETWEEN HUMAN 5-HT1D SUBTYPES

      Naunyn-Schmiedeberg's archives of pharmacology
    42. PICKER MJ; BENYAS S; HORWITZ JA; THOMPSON K; MATHEWSON C; SMITH MA
      DISCRIMINATIVE STIMULUS EFFECTS OF BUTORPHANOL - INFLUENCE OF TRAINING DOSE ON THE SUBSTITUTION PATTERNS PRODUCED BY MU-OPIOID, KAPPA-OPIOID AND DELTA-OPIOID AGONISTS

      The Journal of pharmacology and experimental therapeutics
    43. HUGHES CE; PICKER MJ; DYKSTRA LA
      TOLERANCE AND CROSS-TOLERANCE TO THE RESPONSE RATE-DECREASING EFFECTSOF MU-OPIOIDS IN MORPHINE-MAINTAINED SQUIRREL-MONKEYS

      Behavioural pharmacology
    44. SMITH MA; PICKER MJ
      EXAMINATION OF THE KAPPA-AGONIST AND ANTAGONIST PROPERTIES OF OPIOIDSIN THE RAT DRUG DISCRIMINATION PROCEDURE - INFLUENCE OF TRAINING DOSEAND INTRINSIC EFFICACY

      Behavioural pharmacology
    45. BOUAZIZ H; HEWITT C; EISENACH JC
      SUBARACHNOID NEOSTIGMINE POTENTIATION OF ALPHA(2)-ADRENERGIC AGONIST ANALGESIA - DEXMEDETOMIDINE VERSUS CLONIDINE

      Regional anesthesia
    46. HOYOVADILLO C; MANDEMA JW; DANHOF M
      PHARMACODYNAMIC INTERACTION BETWEEN MIDAZOLAM AND A LOW-DOSE OF ETHANOL IN-VIVO

      Life sciences
    47. DUTTAROY A; YOBURN BC
      THE EFFECT OF INTRINSIC EFFICACY ON OPIOID TOLERANCE

      Anesthesiology
    48. PICKER MJ; SMITH MA; MORGAN D
      ASSESSMENT OF THE RELATIVE INTRINSIC EFFICACY OF PROFADOL AND MEPERIDINE IN A PIGEON DRUG DISCRIMINATION PROCEDURE - RELEVANCE TO PARTIAL SUBSTITUTION PATTERNS

      Behavioural pharmacology
    49. BOTTLAENDER M; BROUILLET E; VARASTET M; LEBRETON C; SCHMID L; FUSEAU C; SITBON R; CROUZEL C; MAZIERE M
      IN-VIVO HIGH INTRINSIC EFFICACY OF TRIAZOLAM - A POSITRON EMISSION TOMOGRAPHY STUDY IN NONHUMAN-PRIMATES

      Journal of neurochemistry
    50. SVENSSON K; ERIKSSON E; CARLSSON A
      PARTIAL DOPAMINE-RECEPTOR AGONISTS REVERSE BEHAVIORAL, BIOCHEMICAL AND NEUROENDOCRINE EFFECTS OF NEUROLEPTICS IN THE RAT - POTENTIAL TREATMENT OF EXTRAPYRAMIDAL SIDE-EFFECTS

      Neuropharmacology
    51. MARTIN JR; SCHOCH P; JENCK F; MOREAU JL; HAEFELY WE
      PHARMACOLOGICAL CHARACTERIZATION OF BENZODIAZEPINE RECEPTOR LIGANDS WITH INTRINSIC EFFICACIES RANGING FROM HIGH TO ZERO

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 01:36:54